Genetic Variation and Stroke Recovery: The STRONG Study
Steven C Cramer,Livia Parodi,Zahra Moslemi,Robynne G Braun,Chad M Aldridge,Babak Shahbaba,Jonathan Rosand,E Alison Holman,STRONG Study Investigators,Shreyansh Shah,Christoph J Griessenauer,Nirav Patel,Christopher Anderson,Jonathan Henry,Christina Kourkoulis,David J Lin,Natalie Zaba,Joey Gee,Johnson Moon,Julie Schwertfeger,Arun Jayaraman,Robert Lee,Maarten G Lansberg,Stephanie Kemp,Emily Huang,Elijah Bingham,Leonel Lugo,Da Eun Katie Eun,Jeremy Payne,Carolynn Patten,Kwan Ng,Madelyn Cao,Ashley Jubb,Breann McGee,Ryan Shahbaba,Kunal Agrawal,Brett Kissela,Stacey DeJong,John Cole,Brian Silver,Christina Manxhari,Brett Cucchiara,Ania Busza,Jennifer Paige Hepple,Sook-Lei Liew,Susan Alderman,Jennifer Beauchamp,Nitha Joseph Mathew,Heather Hayes,Jennifer J Majersik,Bradford B Worrall,David Tirschwell,Cheryl Bushnell,Nada El Husseini,Jin-Moo Lee,Guido J Falcone
DOI: https://doi.org/10.1161/STROKEAHA.124.047643
IF: 10.17
Stroke
Abstract:Background: Genetic association studies can reveal biology and treatment targets but have received limited attention for stroke recovery. STRONG (Stroke, Stress, Rehabilitation, and Genetics) was a prospective, longitudinal (1-year), genetic study in adults with stroke at 28 US stroke centers. The primary aim was to examine the association that candidate genetic variants have with (1) motor/functional outcomes and (2) stress-related outcomes. Methods: For motor/functional end points, 3 candidate gene variants (ApoE ε4, BDNF [brain-derived neurotrophic factor], and a dopamine polygenic score) were analyzed for associations with change in grip strength (3 months-baseline), function (3-month Stroke Impact Scale-Activities of Daily Living), mood (3-month Patient Health Questionnaire-8), and cognition (12-month telephone-Montreal Cognitive Assessment). For stress-related outcomes, 7 variants (serotonin transporter gene-linked promoter region, ACE [angiotensin-converting enzyme], oxytocin receptor, FKBP5 [FKBP prolyl isomerase 5], FAAH [fatty acid amide hydrolase], BDNF, and COMT [catechol-O-methyltransferase]) were assessed for associations with posttraumatic stress disorder ([PTSD]; PTSD Primary Care Scale) and depression (Patient Health Questionnaire-8) at 6 and 12 months; stress-related genes were examined as a function of poststroke stress level. Statistical models (linear, negative binomial, or Poisson regression) were based on response variable distribution; all included stroke severity, age, sex, and ancestry as covariates. Stroke subtype was explored secondarily. Data were Holm-Bonferroni corrected. A secondary replication analysis tested whether the rs1842681 polymorphism (identified in the GISCOME study [Genetics of Ischaemic Stroke Functional Outcome]) was related to 3-month modified Rankin Scale score in STRONG. Results: The 763 enrollees were 63.1±14.9 (mean±SD) years of age, with a median initial National Institutes of Health Stroke Scale score of 4 (interquartile range, 2-9); outcome data were available in n=515 at 3 months, n=500 at 6 months, and n=489 at 12 months. At 1 year poststroke, the rs6265 (BDNF) variant was associated with poorer cognition (0.9-point lower telephone-Montreal Cognitive Assessment score, P=1×10-5). For stress-related outcomes, rs4291 (ACE) and rs324420 (FAAH) were risk factors linking increased poststroke stress with higher 1-year depression and PTSD symptoms (P<0.05), while rs4680 (COMT) linked poststroke stress with lower 1-year depression and PTSD. Findings were unchanged when considering stroke subtype. STRONG replicated GISCOME: rs1842681 was associated with lower 3-month modified Rankin Scale score (P=3.2×10-5). Conclusions: This study identified genetic associations with cognitive function, depression, and PTSD 1 year poststroke. Genetic susceptibility to PTSD and depressive symptoms varied according to the amount of poststroke stress, underscoring the critical role of lived experiences in recovery. Together, the results suggest that genetic association studies provide insights into the biology of stroke recovery in humans.